Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are CRF receptor antagonists potential antidepressants?

Donna O'Brien1, Kelly H Skelton, Michael J Owens

  • 1Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.

Human Psychopharmacology
|October 31, 2002
PubMed
Summary

Corticotropin-releasing factor (CRF) regulates stress responses and is implicated in depression. CRF receptor antagonists show promise for treating mood and anxiety disorders by blocking these stress effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generalizable structure-function covariation predictive of antidepressant response revealed by target-oriented multimodal fusion.

Nature. Mental health·2026
Same author

The effect of cumulative trauma load on suicide risk and thoughts in trauma-exposed youth over two years.

Journal of affective disorders·2026
Same author

Anhedonia in patients with major depressive disorder (MDD): State-of-the-art consensus review.

Psychiatry research·2026
Same author

Progress on Pharmacogenetic Tests for Antidepressant Drug Selection Requires Properly Designed Studies.

Journal of clinical psychopharmacology·2026
Same author

Childhood Maltreatment in the Context of Familial Bipolar I Disorder Risk Predicts Major Depressive Disorder in Adolescents.

JAACAP open·2026
Same author

Relationships Among Dementia, Parental Death, and Other Adverse Childhood Experiences: Systematic Review and Meta-Analysis.

The Journal of neuropsychiatry and clinical neurosciences·2026

Area of Science:

  • Neuroendocrinology
  • Psychiatry

Background:

  • Corticotropin-releasing factor (CRF) is a key regulator of the hypothalamic-pituitary-adrenal (HPA) axis, orchestrating stress responses.
  • CRF administration in the central nervous system (CNS) mimics mammalian stress responses.
  • Dysregulation of CRF and HPA axis hyperactivity are implicated in the pathophysiology of depression.

Purpose of the Study:

  • To investigate the role of CRF in stress and depression.
  • To evaluate the potential of CRF receptor antagonists in treating affective and anxiety disorders.

Main Methods:

  • Administration of CRF and CRF antagonists to laboratory animals.
  • Assessment of behavioral and physiological stress responses.
  • Evaluation of anxiolytic and antidepressant activity in animal models.

Related Experiment Videos

Main Results:

  • CNS administration of CRF induces a stress-like response.
  • CRF antagonists block stress responses induced by exogenous or natural stressors.
  • CRF receptor antagonists demonstrate anxiolytic and antidepressant effects in animal models.

Conclusions:

  • CRF plays a critical role in mediating stress responses.
  • Hypersecretion of CRF and HPA axis hyperactivity are linked to depression.
  • Selective CRF(1) receptor antagonists represent a potential therapeutic strategy for depression and anxiety disorders.